Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1346

1.
2.

Hypertriglyceridemia, an important and independent risk factor for acute pancreatitis in patients with type 2 diabetes mellitus.

Albai O, Roman D, Frandes M.

Ther Clin Risk Manag. 2017 Apr 13;13:515-522. doi: 10.2147/TCRM.S134560. eCollection 2017.

3.
4.

Education achievement and type 2 diabetes-what mediates the relationship in older adults? Data from the ESTHER study: a population-based cohort study.

Steele CJ, Schöttker B, Marshall AH, Kouvonen A, O'Doherty MG, Mons U, Saum KU, Boffetta P, Trichopoulou A, Brenner H, Kee F.

BMJ Open. 2017 Apr 17;7(4):e013569. doi: 10.1136/bmjopen-2016-013569.

5.

Type 2 diabetes mellitus unawareness, prevalence, trends and risk factors: National Health and Nutrition Examination Survey (NHANES) 1999-2010.

Zhang N, Yang X, Zhu X, Zhao B, Huang T, Ji Q.

J Int Med Res. 2017 Apr;45(2):594-609. doi: 10.1177/0300060517693178. Epub 2017 Mar 21.

PMID:
28415936
6.

A Study to Assess the Therapeutic Effect of Enalapril on Olanzapine Induced Metabolic Syndrome in Wistar Rats.

Arivazhahan A, Bairy LK, Nayak V, Kunder SK.

J Clin Diagn Res. 2017 Feb;11(2):FF01-FF06. doi: 10.7860/JCDR/2017/24049.9380. Epub 2017 Feb 1.

7.

Prevalence and pattern of dyslipidemia in Nepalese individuals with type 2 diabetes.

Pokharel DR, Khadka D, Sigdel M, Yadav NK, Acharya S, Kafle R, Sapkota RM, Sigdel T.

BMC Res Notes. 2017 Apr 4;10(1):146. doi: 10.1186/s13104-017-2465-4.

8.

Association of renal function with clinical parameters and conditions in a longitudinal population-based epidemiological study.

Sumi T, Oguri M, Fujimaki T, Horibe H, Kato K, Matsui K, Takeuchi I, Murohara T, Yamada Y.

Biomed Rep. 2017 Feb;6(2):242-250. doi: 10.3892/br.2016.831. Epub 2016 Dec 23.

9.

Integrated Yoga and Naturopathy module in management of Metabolic Syndrome: A case report.

Gowda S, Mohanty S, Saoji A, Nagarathna R.

J Ayurveda Integr Med. 2017 Jan - Mar;8(1):45-48. doi: 10.1016/j.jaim.2016.10.006. Epub 2017 Mar 16.

10.

Development and Validation of a Model for Predicting Diabetic Nephropathy in Chinese People.

Chen L, Sun KX, Juan J, Fang K, Liu K, Wang XY.

Biomed Environ Sci. 2017 Feb;30(2):106-112. doi: 10.3967/bes2017.014.

11.

Heritability, parental transmission and environment correlation of pediatric-onset type 2 diabetes mellitus and metabolic syndrome-related traits.

Miranda-Lora AL, Vilchis-Gil J, Molina-Díaz M, Flores-Huerta S, Klünder-Klünder M.

Diabetes Res Clin Pract. 2017 Apr;126:151-159. doi: 10.1016/j.diabres.2017.02.005. Epub 2017 Feb 10.

PMID:
28242438
12.

Metabolic syndrome's risk factors and its association with nutritional status in schoolchildren.

Teixeira FC, Pereira FE, Pereira AF, Ribeiro BG.

Prev Med Rep. 2017 Feb 8;6:27-32. doi: 10.1016/j.pmedr.2017.02.002. eCollection 2017 Jun.

13.

Prevalence of risk factors and asymptomatic carotid atherosclerosis in diabetic patients screened for silent myocardial ischemia by SPECT myocardial imaging.

Mitevska IP, Baneva N, Bosevski M, Kostovska ES.

Nucl Med Rev Cent East Eur. 2017;20(1):3-9. doi: 10.5603/NMR.a2016.0039.

14.

Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome.

Davies MJ, Merton KW, Vijapurkar U, Balis DA, Desai M.

Diabetes Metab Syndr Obes. 2017 Jan 27;10:47-55. doi: 10.2147/DMSO.S126291. eCollection 2017.

15.

Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.

van den Berg EH, Amini M, Schreuder TC, Dullaart RP, Faber KN, Alizadeh BZ, Blokzijl H.

PLoS One. 2017 Feb 2;12(2):e0171502. doi: 10.1371/journal.pone.0171502. eCollection 2017.

16.

Effect of Nigella sativa supplementation over a one-year period on lipid levels, blood pressure and heart rate in type-2 diabetic patients receiving oral hypoglycemic agents: nonrandomized clinical trial.

Badar A, Kaatabi H, Bamosa A, Al-Elq A, Abou-Hozaifa B, Lebda F, Alkhadra A, Al-Almaie S.

Ann Saudi Med. 2017 Jan-Feb;37(1):56-63. doi: 10.5144/0256-4947.2017.56.

17.

[Prevalence of cardiovascular risk factors in a rural Aymara population from northern Chile].

Vargas M P, Saavedra P S, Araya A MV, Loyola A K, Huerta G P, Silva A M, Araya C S, Saavedra A W, Portales P P, Saavedra P W.

Rev Med Chil. 2016 Sep;144(9):1144-1149. doi: 10.4067/S0034-98872016000900007. Spanish.

18.

The metabolic syndrome and its components in pediatric survivors of allogeneic hematopoietic stem cell transplantation.

Bielorai B, Weintraub Y, Hutt D, Hemi R, Kanety H, Modan-Moses D, Goldstein G, Hadar D, Lerner-Geva L, Toren A, Pinhas-Hamiel O.

Clin Transplant. 2017 Mar;31(3). doi: 10.1111/ctr.12903. Epub 2017 Feb 1.

PMID:
28039914
19.

Metabolic Vascular Syndrome: New Insights into a Multidimensional Network of Risk Factors and Diseases.

Scholz GH, Hanefeld M.

Visc Med. 2016 Oct;32(5):319-326. Epub 2016 Oct 7. Review.

PMID:
27921043
20.

Lipid Accumulation Product (LAP) as an Index of Metabolic and Hormonal Disorders in Aging Men.

Rotter I, Rył A, Szylińska A, Pawlukowska W, Lubkowska A, Laszczyńska M.

Exp Clin Endocrinol Diabetes. 2017 Mar;125(3):176-182. doi: 10.1055/s-0042-116071. Epub 2016 Nov 29.

PMID:
27898988

Supplemental Content

Loading ...
Support Center